Biogen
Get Full AccessDescription
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS) SPINRAZA for spinal muscular atrophy and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL IMRALDI, an adalimumab biosimilar referencing HUMIRA and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL GAZYVA to treat CLL and follicular lymphoma and OCREVUS for treating relapsing MS and primary progressive MS and other anti-CD20 therapies. Further, it develops BIIB061, BIIB091, and BIIB107 for MS and neuroimmunology Aducanumab, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia BIIB067, BIIB078, BIIB105, BIIB100, and BIIB110 to treat neuromuscular disorders BIIB124, BIIB094, BIIB118, BIIB101, and BIIB122 for treating Parkinson's disease and movement disorders BIIB111 and BIIB112 to treat ophthalmology related diseases BIIB125 and BIIB104 for treating neuropsychiatry Dapirolizumab pegol and BIIB059 to treat immunology related diseases BIIB093 and TMS-007 to treat acute neurology BIIB074 and BIIB095 for neuropathic pain and SB11 and SB15 biosimilars, which are under various stages of development. The company has collaboration and license agreements with Acorda Therapeutics, Inc. Alkermes Pharma Ireland Limited Bristol-Myers Squibb Company Eisai Co., Ltd. Genentech, Inc. Neurimmune SubOne AG Ionis Pharmaceuticals, Inc. Ginkgo Bioworks and Capsigen Inc. Biogen Inc. was founded in 1978 and is headquartered in Cambridge, Massachusetts.
-
Headquarters:225 Binney Street , Cambridge, Massachusetts, United States
More -
Phone Number: +1 781-464-2000
-
Website: https://www.biogen.com
-
Employees:9430
-
Revenue:> $1B
-
Legal Name:Biogen
-
Biogen's Social Media
-
Is this data correct?
-
| NAICS Code: 621111 |
NYSE: BIIB
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Biogen
-
Where are Biogen's Headquarters?
Biogen's Headquarters are in 225 Binney Street ,Cambridge,Massachusetts,United States
-
What is Biogen's phone number?
Biogen's phone number is +1 781-464-2000
-
What is Biogen's stock symbol?
Biogen's stock symbol is BIIB
-
What is Biogen's official website?
Biogen's official website is https://www.biogen.com
-
What is Biogen's Revenue?
Biogen's revenue is > $1B
-
What is Biogen's NAICS code?
Biogen's NAICS code is 621111
-
How many employees are working in Biogen
Biogen has 9430 employees
-
What is Biogen's Industry?
Biogen is in the industry of Biotechnology